These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3589153)

  • 1. Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology.
    Wilson H; Rocci ML; Weber KT; Andrews V; Likoff MJ
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):3-19. PubMed ID: 3589153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
    Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
    Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
    Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the bipyridines amrinone and milrinone.
    Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
    Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
    Chu KM; Shieh SM; Hu OY
    Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative experience with amrinone.
    Levy JH; Bailey JM
    Eur J Anaesthesiol Suppl; 1992; 5():15-9. PubMed ID: 1600963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of amrinone in the treatment of heart insufficiency in intensive care].
    Costa P; Agrò C; Gulotta G; Papa G; Piazza F; Ronga F; Sparacia B; Sansone A
    Minerva Anestesiol; 1992 May; 58(5):301-10. PubMed ID: 1635643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
    Fosse JP; Pourriat JL; Hoang P; Fournier JL; Aïtkaciali F; Cupa M
    Cah Anesthesiol; 1989 Dec; 37(8):581-5. PubMed ID: 2637778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG; Dametto E; Maragno I; Razzolini R; Chinellato P; Santostasi G; Dalla Volta S
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of amrinone on patients with moderate and severe cardiac dysfunction after open heart surgery].
    Kunimoto F; Arai K; Isa Y; Satoh Y; Fujita T; Koyano T; Nagasawa S; Ohbayashi T; Kaneko T
    Masui; 1995 Jan; 44(1):42-50. PubMed ID: 7699823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral and injectable amrinone in cardiac insufficiency].
    Massabuau P; Puel J; Miquel JP; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1984; 33(4):223-6. PubMed ID: 6465816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Mao ZL; Stalker D; Keirns J
    Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.